Phase II clinical trial to determine if polyphenon E inhibits c-met signaling and activation of pathways contributing to breast cancer progression
Phase of Trial: Phase II
Latest Information Update: 27 Sep 2017
At a glance
- Drugs Polyphenon E (Primary)
- Indications Advanced breast cancer; Early breast cancer
- Focus Biomarker; Therapeutic Use
- 23 Sep 2017 Status changed from active, no longer recruiting to completed.
- 10 Jun 2017 Biomarkers information updated
- 25 Oct 2012 Planned End Date changed from 1 Jul 2012 to 1 Jul 2013 as reported by ClinicalTrials.gov.